Can a malaria drug help kids with a rare kidney disease?
NCT ID NCT04937907
First seen Mar 13, 2026 · Last updated May 13, 2026 · Updated 5 times
Summary
This study tested whether hydroxychloroquine, a drug used for malaria and autoimmune conditions, can reduce blood and protein in the urine of children with X-linked Alport syndrome, a genetic kidney disease. Fifty children aged 3-18 with stable kidney function took the drug for 48 weeks. The goal was to see if it could control kidney damage, not cure the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALPORT SYNDROME, X-LINKED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Children's Hospital
Shanghai, Shanghai Municipality, 200062, China
Conditions
Explore the condition pages connected to this study.